Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04310605
Other study ID # ECP-152 05_12_2014
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2014
Est. completion date November 16, 2016

Study information

Verified date March 2020
Source Maastricht University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is an observational study of specialised CBT for tinnitus for adults delivered in routine care.


Recruitment information / eligibility

Status Completed
Enrollment 403
Est. completion date November 16, 2016
Est. primary completion date November 16, 2016
Accepts healthy volunteers
Gender All
Age group 17 Years and older
Eligibility Inclusion Criteria:

- Tinnitus is the primary complaint and reason for seeking help

- Participant is at least 17 years of age,

Exclusion Criteria:

- Unable to read and write in Dutch

- Tinnitus is not the primary complaint

- Person is under 17 years of age

- Participant has a health condition that prevents them from attending treatment centre

- An Ear Nose Throat (ENT) physician assesses the participant as having ontological condition that requires medical treatment

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
CBT 1
CBT for tinnitus (Step 1) comprised: individual audiometric assessment, and counselling about hearing and tinnitus (1hr) with an audiologist; a one-off educational group session (a max 10 participants and partners) (2hrs); an assessment session with a psychologists (1 hr).
CBT 2
Step 2 group sessions were 2 hrs long over a 12-week period. Two therapists (a psychologist and physiotherapist) were present at any one time for Step 2 sessions. Step 2 included: psycho-education; exposure therapy; mindfulness exercises; cognitive restructuring; attention redirecting techniques; stress reduction; and, relaxation techniques. Evening sessions were also provided for participants to attend with family or partners.

Locations

Country Name City State
n/a

Sponsors (5)

Lead Sponsor Collaborator
Maastricht University Flemish Government, Belgium, Libra Revalidatie en Audiologie, SWOL Limburgs Fonds voor Revalidatie, The Netherlands Organization for Scientific Research (NWO)

References & Publications (1)

Cima RF, Maes IH, Joore MA, Scheyen DJ, El Refaie A, Baguley DM, Anteunis LJ, van Breukelen GJ, Vlaeyen JW. Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial. Lancet. 2012 May 26;379(9830):1951-9. doi: 10.1016/S0140-6736(12)60469-3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Health Utilities Index-III The Health Utilities Index (HUI; Feeny et al., 2002; Horsman, Furlong, Feeny, & Torrance, 2003) is a 17-item measure designed to assess health related quality of life. 12 months
Secondary Tinnitus Handicap Inventory (THI) The THI (Newman, Jacobson, & Spitzer, 1996; Newman, Sandridge, & Jacobson, 1998).is a 25 items measure of the impact of tinnitus on daily life that includes three subscales. The subscales cover functional (mental, social/occupational and physical functioning), emotional impact and catastrophic responses to tinnitus. 12 months
Secondary Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983). The HADS is a widely used measure of psychological distress in people experiencing a concurrent physical health condition. It has 14 items and respondents use a Likert-type scale to indicate how often they have had a particular feeling in the previous week (e.g. "I feel tense or wound up"). 12 months
Secondary Tinnitus Catastrophizing Scale (TCS) Tinnitus Catastrophizing Scale (TCS; Cima, Crombez, & Vlaeyen, 2011). The TCS was used to assess the degree to which people thought or expected the worst about tinnitus (i.e. catastrophizing). The TCS is a 13-item measure based on the Pain Catastrophizing Scale (Sullivan, Bishop, & Pivik, 1995) and respondents use a five point scale to indicate the degree to which statements applies to them (e.g. It's terrible and I think it's never going to get any better). The total score on the TCS ranges from 0 to 65. 12 months
Secondary Fear of Tinnitus Questionnaire (FTQ) The FTQ is a 17-item self-report measure intended and designed to assess respondents' level of fear regarding their tinnitus. Items in the questionnaire are presented as a series of statements (e.g. "I am afraid that my tinnitus will become worse") from which respondents are asked to indicate if it is applicable to their current situation. Each statement receives a score of 1 when applicable. The total score is the sum of all applicable statements and provides an overall rating of fear of tinnitus and ranges from 0 to 17. 12 months
Secondary Tinnitus Questionnaire (TQ) The Tinnitus Questionnaire (TQ; Hallam, Jakes, & Hinchcliffe, 1988) is a self-report questionnaire designed to asses distress and interference in daily activities that is associated with tinnitus. It has 52 items and uses a three-point scale to indicate levels of distress on six subscales. The total possible score on the TQ ranges from 0-84. 12 months
Secondary Tinnitus Disability Index (TDI) The Tinnitus Disability Index (TDI; Cima, Vlaeyen, Maes, Joore, & Anteunis, 2011) is a seven-item self-report questionnaire that assesses the level of interferences in daily activities (such as occupational, social, and recreational) attributed to tinnitus. Respondents use an 11-point scale to indicate the level of interference ranging from 0 no disability, to 10 total disability. The total score ranges from 0 to 70 with higher scores indicating higher levels of interference. 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04987502 - Virtual Reality and Subjective Tinnitus N/A
Completed NCT04281953 - Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
Recruiting NCT04404439 - Treatment of Tinnitus With Migraine Medications Phase 4
Completed NCT03782220 - Effects of Kinesio Taping in Patients With Somatosensory Tinnitus N/A
Completed NCT05711641 - Action of Intra-auricular Topical Lidocaine on Tinnitus N/A
Completed NCT03711630 - Impact of Meditation on Bothersome Tinnitus N/A
Completed NCT05591144 - Short-term Oral Steriods for Acute Tinnitus N/A
Completed NCT04565132 - HD-tDCS as a Treatment for Chronic Tinnitus N/A
Completed NCT02315508 - Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo Phase 2
Active, not recruiting NCT03888521 - Evaluating the GN ReSound Relief App Using task-and Rest-based fMRI N/A
Not yet recruiting NCT05507372 - Treatment for Post Acute COVID-19 Syndrome N/A
Recruiting NCT05198973 - Bumblebee Breath Effect on Tinnitus in Older Patients N/A
Not yet recruiting NCT04623957 - Safety and Efficacy of Acupressure Applied Through ForgTin© in Patients With Tinnitus N/A
Recruiting NCT05964725 - The Study on Effect and Neural Network Mechanism of Transcranial Direct Current Stimulation for Sudden Deafness With Tinnitus N/A
Not yet recruiting NCT05417711 - Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus N/A
Recruiting NCT04162405 - Tinnitus in Patients With and Without Sensorineural Hearing Loss
Completed NCT03716544 - Efficacy of Amplification With Hearing Aids for Tinnitus Relief N/A
Completed NCT04127708 - Tinnitus and Acupuncture N/A
Completed NCT03638986 - Comparison of the Two Validated German Versions of the "Tinnitus Functional Index" for Switzerland and for Germany
Enrolling by invitation NCT04382807 - Internet-delivered Group Counseling for Chronic Tinnitus